1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Wet AMD
  • 1.2.3 Dry AMD
• 1.3 Market by Application
  • 1.3.1 Global Age Related Macular Degeneration (AMD) Market Share by Application: 2020 VS 2026
  • 1.3.2 Men
  • 1.3.3 Woman
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2015-2026)
• 2.2 Global Age Related Macular Degeneration (AMD) Growth Trends by Regions
  • 2.2.1 Age Related Macular Degeneration (AMD) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Age Related Macular Degeneration (AMD) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Age Related Macular Degeneration (AMD) Players by Market Size
  • 3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2015-2020)
  • 3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2015-2020)
• 3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
• 3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
  • 3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2019
• 3.5 Key Players Age Related Macular Degeneration (AMD) Area Served
• 3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
• 3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Age Related Macular Degeneration (AMD) Breakdown Data by Type (2015-2026)

• 4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2015-2020)
• 4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2021-2026)

5 Age Related Macular Degeneration (AMD) Breakdown Data by Application (2015-2026)

• 5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2015-2020)
• 5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Age Related Macular Degeneration (AMD) Market Size (2015-2026)
• 6.2 North America Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
• 6.3 North America Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
• 6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2015-2026)
• 7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
• 7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
• 7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Age Related Macular Degeneration (AMD) Market Size (2015-2026)
• 8.2 China Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
• 8.3 China Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
• 8.4 China Age Related Macular Degeneration (AMD) Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Age Related Macular Degeneration (AMD) Market Size (2015-2026)
• 9.2 Japan Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
• 9.3 Japan Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
• 9.4 Japan Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Age Related Macular Degeneration (AMD) Market Size (2015-2026)
• 10.2 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type (2015-2020)
• 10.3 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application (2015-2020)
• 10.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Company Details
  • 11.1.2 Bayer Business Overview
  • 11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
  • 11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2015-2020))
  • 11.1.5 Bayer Recent Development
• 11.2 F. HoffmannLa Roche
  • 11.2.1 F. HoffmannLa Roche Company Details
  • 11.2.2 F. HoffmannLa Roche Business Overview
  • 11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
  • 11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2015-2020)
  • 11.2.5 F. HoffmannLa Roche Recent Development
• 11.3 Regeneron
  • 11.3.1 Regeneron Company Details
  • 11.3.2 Regeneron Business Overview
  • 11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
  • 11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2015-2020)
  • 11.3.5 Regeneron Recent Development
• 11.4 Novartis
  • 11.4.1 Novartis Company Details
  • 11.4.2 Novartis Business Overview
  • 11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
  • 11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2015-2020)
  • 11.4.5 Novartis Recent Development
• 11.5 Valeant
  • 11.5.1 Valeant Company Details
  • 11.5.2 Valeant Business Overview
  • 11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
  • 11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2015-2020)
  • 11.5.5 Valeant Recent Development
• 11.6 Pfizer
  • 11.6.1 Pfizer Company Details
  • 11.6.2 Pfizer Business Overview
  • 11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
  • 11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2015-2020)
  • 11.6.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Age Related Macular Degeneration (AMD) Scope and Market Size
Age Related Macular Degeneration (AMD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Age Related Macular Degeneration (AMD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Wet AMD
Dry AMD

Market segment by Application, split into
Men
Woman

Based on regional and country-level analysis, the Age Related Macular Degeneration (AMD) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Age Related Macular Degeneration (AMD) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
...